HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stewart, R. J. Articles by Weitz, J. I. Search for Related Content PubMed PubMed Citation Articles by Stewart, R. J. Articles by Weitz, J. I. Social Bookmarking                      What's this?

J Biol Chem, Vol. 275, Issue 14, 10112-10120, April 7, 2000

Identification of the Mechanism Responsible for the Increased Fibrin Specificity of TNK-Tissue Plasminogen Activator Relative to Tissue Plasminogen Activator^*

Ronald J. Stewart^§, James C. Fredenburgh, Beverly A. Leslie, Bruce A. Keyt^¶, Janice A. Rischke, and Jeffrey I. Weitz

From the  Hamilton Civic Hospitals Research Centre and McMaster University, Hamilton, Ontario L8V 1C3, Canada and ^¶ Genentech, Inc., South San Francisco, California 94080

TNK-tissue plasminogen activator (TNK-t-PA), a bioengineered variant of tissue-type plasminogen activator (t-PA), has a longer half-life than t-PA because the glycosylation site at amino acid 117 (N117Q, abbreviated N) has been shifted to amino acid 103 (T103N, abbreviated T) and is resistant to inactivation by plasminogen activator inhibitor 1 because of a tetra-alanine substitution in the protease domain (K296A/H297A/R298A/R299A, abbreviated K). TNK-t-PA is more fibrin-specific than t-PA for reasons that are poorly understood. Previously, we demonstrated that the fibrin specificity of t-PA is compromised because t-PA binds to (DD)E, the major degradation product of cross-linked fibrin, with an affinity similar to that for fibrin. To investigate the enhanced fibrin specificity of TNK-t-PA, we compared the kinetics of plasminogen activation for t-PA, TNK-, T-, K-, TK-, and NK-t-PA in the presence of fibrin, (DD)E or fibrinogen. Although the activators have similar catalytic efficiencies in the presence of fibrin, the catalytic efficiency of TNK-t-PA is 15-fold lower than that for t-PA in the presence of (DD)E or fibrinogen. The T and K mutations combine to produce this reduction via distinct mechanisms because T-containing variants have a higher K_M, whereas K-containing variants have a lower k_cat than t-PA. These results are supported by data indicating that T-containing variants bind (DD)E and fibrinogen with lower affinities than t-PA, whereas the K and N mutations have no effect on binding. Reduced efficiency of plasminogen activation in the presence of (DD)E and fibrinogen but equivalent efficiency in the presence of fibrin explain why TNK-t-PA is more fibrin-specific than t-PA.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				T. Nassar, S.'e. Akkawi, A. Shina, A. Haj-Yehia, K. Bdeir, M. Tarshis, S. N. Heyman, and A. A.-R. Higazi In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone Blood, February 1, 2004; 103(3): 897 - 902. [Abstract] [Full Text] [PDF]

				C. H. Pospisil, A. R. Stafford, J. C. Fredenburgh, and J. I. Weitz Evidence That Both Exosites on Thrombin Participate in Its High Affinity Interaction with Fibrin J. Biol. Chem., June 6, 2003; 278(24): 21584 - 21591. [Abstract] [Full Text] [PDF]

				R. J. Stewart, J. C. Fredenburgh, J. A. Rischke, L. Bajzar, and J. I. Weitz Thrombin-activable Fibrinolysis Inhibitor Attenuates (DD)E-mediated Stimulation of Plasminogen Activation by Reducing the Affinity of (DD)E for Tissue Plasminogen Activator. A POTENTIAL MECHANISM FOR ENHANCING THE FIBRIN SPECIFICITY OF TISSUE PLASMINOGEN ACTIVATOR J. Biol. Chem., November 17, 2000; 275(47): 36612 - 36620. [Abstract] [Full Text] [PDF]